Logo image of SCAN.CA

LIBERTY DEFENSE HOLDINGS LTD (SCAN.CA) Stock Fundamental Analysis

TSX-V:SCAN - TSX Venture Exchange - CA53044R8839 - Common Stock - Currency: CAD

0.38  -0.02 (-5%)

Fundamental Rating

0

SCAN gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. SCAN has a bad profitability rating. Also its financial health evaluation is rather negative. SCAN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

SCAN had negative earnings in the past year.
SCAN had a negative operating cash flow in the past year.
In the past 5 years SCAN always reported negative net income.
In the past 5 years SCAN always reported negative operating cash flow.
SCAN.CA Yearly Net Income VS EBIT VS OCF VS FCFSCAN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -2M -4M -6M -8M -10M

1.2 Ratios

Industry RankSector Rank
ROA -210.46%
ROE N/A
ROIC N/A
ROA(3y)-182.11%
ROA(5y)-304.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SCAN.CA Yearly ROA, ROE, ROICSCAN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K

1.3 Margins

SCAN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SCAN.CA Yearly Profit, Operating, Gross MarginsSCAN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 -200 -400 -600

More info and screens

0

2. Health

2.1 Basic Checks

SCAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SCAN has more shares outstanding
The number of shares outstanding for SCAN has been increased compared to 5 years ago.
The debt/assets ratio for SCAN is higher compared to a year ago.
SCAN.CA Yearly Shares OutstandingSCAN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
SCAN.CA Yearly Total Debt VS Total AssetsSCAN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M

2.2 Solvency

Based on the Altman-Z score of -19.26, we must say that SCAN is in the distress zone and has some risk of bankruptcy.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -19.26
ROIC/WACCN/A
WACC9.71%
SCAN.CA Yearly LT Debt VS Equity VS FCFSCAN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M

2.3 Liquidity

A Current Ratio of 0.12 indicates that SCAN may have some problems paying its short term obligations.
SCAN has a Quick Ratio of 0.12. This is a bad value and indicates that SCAN is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.12
Quick Ratio 0.1
SCAN.CA Yearly Current Assets VS Current LiabilitesSCAN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for SCAN have decreased strongly by -537.73% in the last year.
Looking at the last year, SCAN shows a very strong growth in Revenue. The Revenue has grown by 111.08%.
EPS 1Y (TTM)-537.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-827.13%
Revenue 1Y (TTM)111.08%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%177.22%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SCAN.CA Yearly Revenue VS EstimatesSCAN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 500K 1M
SCAN.CA Yearly EPS VS EstimatesSCAN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

SCAN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SCAN.CA Price Earnings VS Forward Price EarningsSCAN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SCAN.CA Per share dataSCAN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SCAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LIBERTY DEFENSE HOLDINGS LTD

TSX-V:SCAN (5/9/2025, 7:00:00 PM)

0.38

-0.02 (-5%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)11-26 2024-11-26
Earnings (Next)05-26 2025-05-26
Inst Owners6.86%
Inst Owner ChangeN/A
Ins Owners1.04%
Ins Owner ChangeN/A
Market Cap19.75M
Analysts80
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.79
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.15
OCFYN/A
SpS0.08
BVpS-0.12
TBVpS-0.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -210.46%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-182.11%
ROA(5y)-304.85%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 20.72%
Cap/Sales 4.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.12
Quick Ratio 0.1
Altman-Z -19.26
F-Score4
WACC9.71%
ROIC/WACCN/A
Cap/Depr(3y)98.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-537.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-827.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)111.08%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%177.22%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y16.17%
OCF growth 3YN/A
OCF growth 5YN/A